Inventor · disambiguated record
Fredrik Tiberg
Also filed as: TIBERG FREDRIK
34 granted patents·30 pending applications·335 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
64 records- 0196US11135215B2Opioid formulationsCAMURUS AB·Filed 2021·Granted Oct 5, 2021·3 cites·30 claims
- 0296US10912772B2Opioid formulationsCAMURUS AB·Filed 2020·Granted Feb 9, 2021·4 cites·16 claims
- 0396US8236755B2Opioid depot formulationsTHURESSON KRISTER·Filed 2007·Granted Aug 7, 2012·51 cites·25 claims
- 0495US8541400B2Compositions forming non-lamellar dispersionsJOHNSSON MARKUS·Filed 2005·Granted Sep 24, 2013·60 cites·22 claims
- 0595US8236292B2Liquid depot formulationsTHURESSON KRISTER·Filed 2005·Granted Aug 7, 2012·41 cites·24 claims
- 0695US8097239B2Controlled-release formulationsJOHNSSON MARKUS·Filed 2007·Granted Jan 17, 2012·42 cites·6 claims
- 0794US12161640B2Opioid formulationsCAMURUS AB·Filed 2023·Granted Dec 10, 2024·1 cites·10 claims
- 0894US11110084B2Opioid formulationsCAMURUS AB·Filed 2021·Granted Sep 7, 2021·2 cites·30 claims
- 0993US8546326B2Glp-1 analogue formulationsJOABSSON FREDRIK·Filed 2006·Granted Oct 1, 2013·28 cites·15 claims
- 1092US8545832B2Lipid depot formulationsTHURESSON KRISTER·Filed 2012·Granted Oct 1, 2013·15 cites·33 claims
- 1191US9585959B2Robust controlled-release formulationsCAMURUS AB·Filed 2012·Granted Mar 7, 2017·16 cites·34 claims
- 1291US2025281407A1Lipid depot formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 1390US9526788B2Pharmaceutical lipid compositionsCAMURUS AB·Filed 2015·Granted Dec 27, 2016·8 cites·25 claims
- 1488US12029813B2Injectable buprenorphine formulationCAMURUS AB·Filed 2021·Granted Jul 9, 2024·1 cites·22 claims
- 1587US12396944B2Injectable buprenorphine formulationCAMURUS AB·Filed 2024·Granted Aug 26, 2025·0 cites·20 claims
- 1687US12318379B2Opioid formulationsCAMURUS AB·Filed 2024·Granted Jun 3, 2025·0 cites·10 claims
- 1787US9937164B2Opioid formulationsCAMURUS AB·Filed 2013·Granted Apr 10, 2018·7 cites·28 claims
- 1886US9649382B2Topical bioadhesive formulationsCAMURUS AB·Filed 2013·Granted May 16, 2017·5 cites·23 claims
- 1986US8920782B2Topical bioadhesive formulationsJOABSSON FREDRIK·Filed 2005·Granted Dec 30, 2014·8 cites·11 claims
- 2086US2025000982A1Peptide slow-release formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 2185US8187629B2Non-lamellar compositions of DOPE and P80BARAUSKAS JUSTAS·Filed 2005·Granted May 29, 2012·16 cites·16 claims
- 2284US9668967B2Lipid formulations comprising a thiolated antioxidantNISTOR CATALIN·Filed 2009·Granted Jun 6, 2017·3 cites·13 claims
- 2383US9974861B2Peptide slow-release formulationsJOHNSSON MARKUS·Filed 2008·Granted May 22, 2018·4 cites·21 claims
- 2483US9968680B2Topical bioadhesive formulationsCAMURUS AB·Filed 2014·Granted May 15, 2018·5 cites·29 claims
- 2583US9555118B2Robust controlled-release peptide formulationsCAMURUS AB·Filed 2012·Granted Jan 31, 2017·5 cites·36 claims
- 2682US9820934B2Acid containing lipid formulationsNISTOR CATALIN·Filed 2008·Granted Nov 21, 2017·2 cites·25 claims
- 2782US2023027339A1Lipid depot formulationsCAMURUS AB·Filed 2022·Application pending·0 cites
- 2881US2025319097A1Prostacyclin analogue formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 2981US2025121035A1Controlled release peptide formulationsCAMURUS AB·Filed 2024·Application pending·0 cites
- 3079US11672843B2Somatostatin receptor agonist formulationsCAMURUS AB·Filed 2013·Granted Jun 13, 2023·1 cites·29 claims
- 3178US8871712B2Somatostatin analogue formulationsJOABSSON FREDRIK·Filed 2005·Granted Oct 28, 2014·2 cites·33 claims
- 3277US2023372436A1Somatostatin receptor agonist formulationsCAMURUS AB·Filed 2023·Application pending·0 cites
- 3374US2021128473A1Lipid depot formulationsCAMURUS AB·Filed 2020·Application pending·0 cites
- 3473US2021268112A1Peptide slow-release formulationsCAMURUS AB·Filed 2021·Application pending·0 cites
- 3573US2022387445A1Prostacyclin analogue formulationsCAMURUS AB·Filed 2022·Application pending·0 cites
- 3669US2021308226A1Controlled release peptide formulationsCAMURUS AB·Filed 2021·Application pending·0 cites
- 3768US2018311163A1Lipid depot formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 3867US2015064118A1Lipid depot formulationsCAMURUS AB·Filed 2014·Application pending·0 cites
- 3966US11369617B2Prostacyclin analogue formulationsCAMURUS AB·Filed 2017·Granted Jun 28, 2022·0 cites·31 claims
- 4066US2019350841A1Lipid formulations comprising a thiolated antioxidantCAMURUS AB·Filed 2018·Application pending·0 cites
- 4165US11433120B2Controlled release peptide formulationsTIBERG FREDRIK·Filed 2012·Granted Sep 6, 2022·1 cites·28 claims
- 4265US8865021B2Compositions of lipids and cationic peptidesJOABSSON FREDRIK·Filed 2004·Granted Oct 21, 2014·2 cites·19 claims
- 4364US2014193347A1Lipid depot formulationsCAMURUS AB·Filed 2013·Application pending·0 cites
- 4462US2019054177A1Peptide slow-release formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 4561US2018250286A1Opioid formulationsCAMURUS AB·Filed 2018·Application pending·0 cites
- 4661US2017281537A1Lipid formulations comprising a thiolated antioxidantCAMURUS AB·Filed 2017·Application pending·0 cites
- 4760US9757461B2GnRH analogue formulationsJOABSSON FREDRIK·Filed 2005·Granted Sep 12, 2017·0 cites·24 claims
- 4860US2014219935A1Topical bioadhesive formulationsCAMURUS AB·Filed 2013·Application pending·0 cites
- 4960US2018078647A1Gnrh analogue formulationsCAMURUS AB·Filed 2017·Application pending·0 cites
- 5060US2020353086A1Controlled-release formulationsCAMURUS AB·Filed 2020·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fredrik Tiberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →